APA (7th ed.) Citation

Schaefer, F., & Mekahli, D. (2019). Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: Rationale and design of a two-part,randomized, double-blind, placebo-controlled trial. European journal of pediatrics, 178(7), . https://doi.org/10.1007/s00431-019-03384-x

Chicago Style (17th ed.) Citation

Schaefer, Franz, and Djalila Mekahli. "Tolvaptan Use in Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Rationale and Design of a Two-part,randomized, Double-blind, Placebo-controlled Trial." European Journal of Pediatrics 178, no. 7 (2019). https://doi.org/10.1007/s00431-019-03384-x.

MLA (9th ed.) Citation

Schaefer, Franz, and Djalila Mekahli. "Tolvaptan Use in Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Rationale and Design of a Two-part,randomized, Double-blind, Placebo-controlled Trial." European Journal of Pediatrics, vol. 178, no. 7, 2019, https://doi.org/10.1007/s00431-019-03384-x.